Shortage reports
Actual shortage:
20 (3%)
Anticipated shortage:
7 (1%)
Avoided shortage:
89 (12%)
Resolved:
650 (85%)
766
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
235 (100%)
Reversed:
0 (0%)
235
100 (10%)
2 (7%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-TENOFOVIR DISOPROXIL | 300MG | TABLET | Avoided shortage | 2022-12-08 | 2023-02-06 | 177336 |
| MYLAN-TENOFOVIR DISOPROXIL | 300MG | TABLET | Avoided shortage | 2020-05-26 | 2020-06-03 | 115765 |
| MYLAN-TENOFOVIR DISOPROXIL | 300MG | TABLET | Actual shortage | 2025-04-23 | 2025-09-23 | 255428 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-10-13 | 2022-02-15 | 25895 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-08-01 | 2022-02-15 | 17787 |
| MYLAN-TOPIRAMATE | 100MG | TABLET | Resolved | 2024-04-01 | 2024-05-15 | 224061 |
| MYLAN-VALACYCLOVIR | 1000MG | TABLET | Actual shortage | 2025-12-01 | 2026-01-13 | 273002 |
| MYLAN-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-06-11 | 2024-06-25 | 230137 |
| MYLAN-VALACYCLOVIR | 500MG | TABLET | Resolved | 2018-03-07 | 2018-04-28 | 42157 |
| MYLAN-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-03-25 | 2024-05-15 | 223279 |
| MYLAN-VALACYCLOVIR | 1000MG | TABLET | Avoided shortage | 2019-04-16 | 2019-04-30 | 81810 |
| MYLAN-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2024-05-21 | 2024-10-04 | 228372 |
| MYLAN-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-05-21 | 2024-06-11 | 228375 |
| MYLAN-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-07-23 | 2024-08-07 | 233559 |
| MYLAN-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2023-10-17 | 2024-05-15 | 207184 |
| MYLAN-VALACYCLOVIR | 500MG | TABLET | Resolved | 2025-11-24 | 2025-12-01 | 272468 |
| MYLAN-VALACYCLOVIR | 500MG | TABLET | Resolved | 2019-04-16 | 2019-05-01 | 81807 |
| MYLAN-VALSARTAN | 40MG | TABLET | Resolved | 2017-05-04 | 2018-07-05 | 9019 |
| MYLAN-VALSARTAN | 320MG | TABLET | Resolved | 2017-05-04 | 2018-07-05 | 9049 |
| MYLAN-VALSARTAN | 160MG | TABLET | Resolved | 2017-10-23 | 2017-11-02 | 26715 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-SIMVASTATIN | 20MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94122 |
| MYLAN-SIMVASTATIN | 10MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94117 |
| MYLAN-SIMVASTATIN | 5MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94112 |
| MYLAN-SIMVASTATIN | 40MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94127 |
| MYLAN-SIMVASTATIN | 80MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94132 |
| MYLAN-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-06-06 | 2018-08-11 | 51624 |
| MYLAN-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-06-06 | 2018-08-11 | 51618 |
| MYLAN-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6814 |
| MYLAN-TELMISARTAN HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6819 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| MYLAN-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Discontinued | 2017-04-13 | 2018-02-15 | 6822 |
| MYLAN-VALSARTAN | 160MG | TABLET | Discontinued | 2017-08-24 | 2017-11-02 | 20284 |
| MYLAN-VALSARTAN | 40MG | TABLET | Discontinued | 2017-08-24 | 2018-07-04 | 20209 |
| MYLAN-VALSARTAN | 80MG | TABLET | Discontinued | 2018-04-04 | 2018-07-04 | 44919 |
| MYLAN-VALSARTAN | 320MG | TABLET | Discontinued | 2017-08-24 | 2018-07-04 | 20217 |
| MYLAN-VALSARTAN HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6827 |
| MYLAN-VALSARTAN HCTZ | 25MG 320MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6845 |
| MYLAN-VALSARTAN HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6841 |
| MYLAN-VALSARTAN HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6833 |